James Valentine
About James Valentine
James Valentine is an In Vitro Assay Development and Screening Specialist with extensive experience in pharmacological research and assay methodologies. He holds an MBA from Rensselaer Polytechnic Institute and has worked at notable companies, including Pfizer Pharmaceuticals and Karos Pharmaceuticals.
Work at Accent Therapeutics
James Valentine currently serves as an In Vitro Assay Development and Screening Specialist at Accent Therapeutics, Inc. since 2020. His role involves coordinating and evaluating pharmacological assays, particularly focused on the prevention of osteoporosis through innovative small molecules. He previously held the same position at Accent Therapeutics from 2018 to 2019, where he began to establish his expertise in assay development and screening methodologies.
Education and Expertise
James Valentine earned a Master of Business Administration (MBA) in Business Management from Rensselaer Polytechnic Institute, where he studied from 1983 to 1986. He also holds a Bachelor of Science (BS) in Agriculture and Natural Resources from the University of Connecticut, completed between 1974 and 1978. Additionally, he obtained a Master of Science (MS) in Pathobiology from the University of Connecticut, studying from 1978 to 1980. His educational background supports his expertise in biological research methodologies.
Background
James Valentine has extensive experience in the pharmaceutical industry, having worked at Pfizer Pharmaceuticals for 29 years in various roles. He began as a Scientist/Sr. Scientist from 1981 to 1994 and later advanced to Research Scientist/Sr. Principal Scientist from 1994 to 2010. Following his tenure at Pfizer, he served as Director of In-Vitro Biology at Karos Pharmaceuticals from 2011 to 2014. His career reflects a strong foundation in scientific research and development.
Achievements
James Valentine has a focus on improving methodologies in biological research, particularly emphasizing the 'How' aspect of scientific inquiry. His work in pharmacological assays, especially in the context of osteoporosis prevention, highlights his contributions to the field. His extensive experience at leading pharmaceutical companies underscores his commitment to advancing scientific knowledge and methodologies.